COMMUNIQUÉS West-GlobeNewswire

BioVie to Present at The MicroCap Conference in New York on April 9th

22/03/2018 - 12:00

BEVERLY, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB:BIVI), a clinical-stage company focused on the development and commercialization of innovative drug therapies for liver disease, announced today that [...]

Zynerba Pharmaceuticals Announces Poster Presentation at the 2018 Annual Meeting of the American Academy of Neurology (AAN)

22/03/2018 - 11:45

DEVON, Pa., March 22, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]

Dental Plans Leaders Take Tax and Market Concerns to the Hill

22/03/2018 - 11:45

WASHINGTON, March 22, 2018 (GLOBE NEWSWIRE) -- National Association of Dental Plans (NADP) members will urge Congressional leaders to extend the moratorium on the Health Insurance Tax (HIT); maintain tax incentives on [...]

Wright Medical Group N.V. Highlights New Product Launches at the American College of Foot and Ankle Surgeons (ACFAS) 2018 Scientific Conference

22/03/2018 - 11:00

AMSTERDAM, The Netherlands, March 22, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI ) today announced that it will highlight new innovations at the American College of Foot and Ankle Surgeons (ACFAS) [...]

Diamond CBD Inc. Exhibits its 100% Natural Organic CBD Oil at The Global Pet Expo in Orlando, Florida

22/03/2018 - 11:00

FT LAUDERDALE, Fla., March 22, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holding, Inc. (OTC Pink:POTN) On Wednesday, the 21st of March, in 2018, PotNetwork Holding, Inc.'s wholly owned subsidiary, Diamond CBD [...]

Zealand Pharma to present at the Needham Healthcare Conference, March 27, 2018 in New York

22/03/2018 - 09:17

Press release - No. 07 / 2018 Zealand Pharma to present at the Needham Healthcare Conference, March 27, 2018 in New York Copenhagen, March 22, 2018 - Britt Meelby Jensen, President and Chief Executive Officer (CEO) of [...]

MDxHealth (R): MDxHealth Successfully Completes a EUR 36 Million (USD 44 million)(1) Capital Increase

22/03/2018 - 08:00

Press release - Regulated information - Inside information - 22 March 2018, 8.00 a.m.CET IRVINE, CA, and HERSTAL, BELGIUM - 22 March 2018 - MDxHealth SA (Euronext Brussels: MDXH), a world leader in molecular diagnostics [...]

MDxHealth (R) : MDxHealth réalise avec succès une augmentation de capital à hauteur de EUR 36 millions (USD 44 millions)(1)

22/03/2018 - 08:00

C ommuniqué de presse - Information règlementée - Information privilégiée - 22 mars 2018, 08h00 HEC I RVINE, CA, et HERSTAL (BELGIQUE) - le 22 mars 2018 - MDxHealth SA (Euronext Brussels: MDXH) un leader mondial dans [...]

Eckert & Ziegler BEBIG: Full-Year 2017 Results, return to profitability is been confirmed

22/03/2018 - 07:46

Press Release Regulated Information Seneffe - Belgium, March 22, 2018 - Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) announced today its consolidated results for the year ending [...]

Eckert & Ziegler BEBIG : Résultats 2017, retour à la rentabilité confirmé

22/03/2018 - 07:46

Informations réglementées Seneffe - Belgique, le 22 mars 2018 - Eckert & Ziegler BEBIG (Euronext : EZBG; Reuters : EZBG.BR; Bloomberg : EZBG:BB) vient d'annoncer aujourd'hui ses résultats consolidés pour l'exercice [...]

IBA SA : IBA Reports Full Year Results for 2017

22/03/2018 - 07:01

IBA Reports Full Year Results for 2017 Louvain-La-Neuve, Belgium, March 22, 2018 - IBA ( Ion Beam Applications SA , EURONEXT), the world's leading provider of proton therapy solutions for the treatment of cancer, today [...]

IBA SA : IBA annonce ses résultats annuels consolidés pour 2017

22/03/2018 - 07:01

IBA annonce ses résultats annuels consolidés pour 2017 Louvain-La-Neuve, Belgique, 22 mars, 2018 - IBA ( Ion Beam Applications SA , EURONEXT), le premier fournisseur mondial de solutions de protonthérapie pour le [...]

VALNEVA Delivers Strong 2017 Financial Results and Advances Key R&D Programs

22/03/2018 - 07:01

Valneva Delivers Strong 2017 Financial Results and Advances Key R&D Programs The Company expects continued double digit product sales growth in 2018 and to invest further in R&D, notably the Lyme and Chikungunya [...]

VALNEVA publie de très bons résultats 2017 et avance sur ses programmes R&D clés

22/03/2018 - 07:01

Valneva publie de très bons résultats 2017 et avance sur ses programmes R&D clés Le Groupe prévoit de maintenir en 2018 une croissance à deux chiffres de ses ventes de produits et d'investir davantage en R&D, [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

22/03/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 22 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

VALNEVA annonce la publication de son Document de Référence

22/03/2018 - 07:01

Valneva annonce la publication de son Document de Référence Lyon (France), 22 mars 2018 - Valneva SE ("Valneva" ou "Le Groupe"), société de biotechnologie dédiée au développement, à la production et à la [...]

argenx announces expansion of its pipeline with addition of complement-targeted ARGX-117 for treatment of severe autoimmune diseases

22/03/2018 - 07:01

Potential for ARGX-117 to have synergistic effect with lead autoimmune compound ARGX-113 March 22, 2018 Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology [...]

Immutep Commences Patient Dosing in Additional TACTI-mel Cohort

21/03/2018 - 23:29

SYDNEY, Australia, March 21, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep” or the “Company”) has announced the initiation of patient dosing in the new cohort of the TACTI-mel ( T wo ACT [...]

RavenQuest Begins Trading on Frankfurt Exchange Under Symbol “1IT”

21/03/2018 - 23:00

VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt: 1IT ) is pleased to announce that it has commenced trading on [...]